Skip to main content
Erschienen in: Abdominal Radiology 11/2019

19.04.2019 | Special Section: Rectal Cancer

Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy

verfasst von: Maria Napoletano, Daniele Mazzucca, Enrico Prosperi, Maria Cristina Aisa, Marco Lupattelli, Cynthia Aristei, Michele Scialpi

Erschienen in: Abdominal Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the added value of qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging (DWI) in locally advanced rectal cancer (LARC) restaging after neoadjuvant chemo-radiotherapy (CRT).

Materials and Methods

A retrospective study was performed of 21 patients with LARC treated with CRT. All patients were evaluated with 1.5 T conventional magnetic resonance imaging (MRI) and DWI (0–1000 s/mm²) before starting therapy and after neoadjuvant CRT. All included patients underwent surgery after CRT: the histopathological evaluation of surgical specimens represented the reference standard for local staging after neoadjuvant therapy. The qualitative analysis was carried out by two operators in consensus, who reviewed the conventional MR image set [T1-weighted and T2-weighted morphological sequences + dynamic contrast-enhanced sequences (DCE)] and the combined set of conventional and DW images. For the quantitative analysis, the apparent diffusion coefficient (ADC) values were measured at each examination. For each lesion, the mean ADC value (ADCpre and ADCpost) and the ΔADC (ADCpost – ADCpre) were calculated, and values of the three groups of response [complete response (pCR), partial response (pPR), stable disease (pSD)] were compared.

Results

In LARC restaging, conventional MRI showed a sensitivity of 80% and a specificity of 50%, with a total diagnostic capacity of 71.40%, while by adding DWI sensitivity increased to 100%, specificity to 67%, and total diagnostic capacity to 90.40%. ΔADC correlates with treatment response and a cutoff of 1.35 × 10−3 mm²/s predicts the pCR with a sensitivity of 93.3% and a specificity of 83.3%.

Conclusions

Adding DWI to conventional sequences may improve MRI capability to evaluate tumor response to CRT. The quantitative DWI assessment is promising, but larger studies are required.
Literatur
1.
Zurück zum Zitat Lezoche G, Baldarelli M, Guerrieri M, et al., A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy, Surg Endosc, 2008;22:352-358.CrossRefPubMed Lezoche G, Baldarelli M, Guerrieri M, et al., A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy, Surg Endosc, 2008;22:352-358.CrossRefPubMed
2.
Zurück zum Zitat Lezoche E, Baldarelli M, Lezoche G, et al., Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy, Br J Surg, 2012;99:1211-1218.CrossRefPubMed Lezoche E, Baldarelli M, Lezoche G, et al., Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy, Br J Surg, 2012;99:1211-1218.CrossRefPubMed
3.
Zurück zum Zitat Habr-Gama A, Perez MO, Nadalin W, et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, 2004;240:711-717.PubMedPubMedCentral Habr-Gama A, Perez MO, Nadalin W, et al., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, 2004;240:711-717.PubMedPubMedCentral
4.
Zurück zum Zitat Marijnen CA, Kapiteijn E, van de Velde CJ, et al., Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial, J Clin Oncol, 2002;20:817-825.CrossRefPubMed Marijnen CA, Kapiteijn E, van de Velde CJ, et al., Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial, J Clin Oncol, 2002;20:817-825.CrossRefPubMed
5.
Zurück zum Zitat Sartori CA, Sartori A, Vigna S, Occhipinti R, Baiocchi GL, Urinary and sexual disorders after laparoscopic TME for rectal cancer in males, J Gastrointest Surg, 2011;15:637-643.CrossRefPubMed Sartori CA, Sartori A, Vigna S, Occhipinti R, Baiocchi GL, Urinary and sexual disorders after laparoscopic TME for rectal cancer in males, J Gastrointest Surg, 2011;15:637-643.CrossRefPubMed
6.
Zurück zum Zitat Maas M, Nelemans PJ, Valentini V, et al., Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol, 2010;11:835-844.CrossRefPubMed Maas M, Nelemans PJ, Valentini V, et al., Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol, 2010;11:835-844.CrossRefPubMed
7.
Zurück zum Zitat Perez RO, Habr-Gama A, Pereira GV, et al., Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?, Colorectal Dis, 2012;14:714-720.CrossRefPubMed Perez RO, Habr-Gama A, Pereira GV, et al., Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?, Colorectal Dis, 2012;14:714-720.CrossRefPubMed
8.
Zurück zum Zitat Hanly AM, Ryan EM, Rogers AC, et al., Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy, Ann Surg, 2014;259:723-727.CrossRefPubMed Hanly AM, Ryan EM, Rogers AC, et al., Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy, Ann Surg, 2014;259:723-727.CrossRefPubMed
9.
Zurück zum Zitat Huh JW, Park YA, Jung EJ, Lee KY, Sohn SK, Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation, J Am Coll Surg, 2008;207:7-12.CrossRefPubMed Huh JW, Park YA, Jung EJ, Lee KY, Sohn SK, Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation, J Am Coll Surg, 2008;207:7-12.CrossRefPubMed
10.
Zurück zum Zitat Curvo-Semedo L, Lambregts DM, Maas M, et al., Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness, J Magn Reson Imaging, 2012;35:1365-1371.CrossRefPubMed Curvo-Semedo L, Lambregts DM, Maas M, et al., Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness, J Magn Reson Imaging, 2012;35:1365-1371.CrossRefPubMed
11.
Zurück zum Zitat Kim SH, Lee JM, Hong SH, et al., Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy, Radiology, 2009;253:116-125.CrossRefPubMed Kim SH, Lee JM, Hong SH, et al., Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy, Radiology, 2009;253:116-125.CrossRefPubMed
12.
Zurück zum Zitat Marouf RA, Tadros MY, Ahmed TY, Value of diffusion-weighted MR imaging in assessing response of neoadjuvant chemo and radiation therapy in locally advanced rectal cancer, Egyptian Journal of Radiology and Nuclear Medicine, 2015;46:553-561.CrossRef Marouf RA, Tadros MY, Ahmed TY, Value of diffusion-weighted MR imaging in assessing response of neoadjuvant chemo and radiation therapy in locally advanced rectal cancer, Egyptian Journal of Radiology and Nuclear Medicine, 2015;46:553-561.CrossRef
13.
Zurück zum Zitat Foti PV, Privitera G, Piana S, et al., Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy, Eur J Radiol Open, 2016;3:145-152.CrossRefPubMedPubMedCentral Foti PV, Privitera G, Piana S, et al., Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy, Eur J Radiol Open, 2016;3:145-152.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bayram I, Bakir B, Kartal MGD, et al., The role of MRI with diffusion-weighted imaging in restaging rectal cancers after neoadjuvant chemoradiotherapy, S Afr J Rad, 2016;20(1):a967.CrossRef Bayram I, Bakir B, Kartal MGD, et al., The role of MRI with diffusion-weighted imaging in restaging rectal cancers after neoadjuvant chemoradiotherapy, S Afr J Rad, 2016;20(1):a967.CrossRef
15.
Zurück zum Zitat The American Joint Commettee on Cancer, AJCC Cancer Staging Manual 8th edition, 2017. The American Joint Commettee on Cancer, AJCC Cancer Staging Manual 8th edition, 2017.
16.
Zurück zum Zitat Szafer A, Zhong J, Anderson AW, Gore JC, Diffusion-weighted imaging in tissues: theoretical models, NMR Biomed, 1995;8:289-96.CrossRefPubMed Szafer A, Zhong J, Anderson AW, Gore JC, Diffusion-weighted imaging in tissues: theoretical models, NMR Biomed, 1995;8:289-96.CrossRefPubMed
17.
Zurück zum Zitat Bassaneze T, Gonçalves JE, Faria JF, Palma RT, Waisberg J, Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy, Radiol Oncol, 2017;51(3):270-276.CrossRefPubMedPubMedCentral Bassaneze T, Gonçalves JE, Faria JF, Palma RT, Waisberg J, Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy, Radiol Oncol, 2017;51(3):270-276.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Jang KM, Kim SH, Choi D, et al., Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results, Br J Radiol, 2012;85:e566-e572.CrossRefPubMedPubMedCentral Jang KM, Kim SH, Choi D, et al., Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results, Br J Radiol, 2012;85:e566-e572.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Pierredon-Foulongne MA, Nougaret S, Bibeau F, et al., Utility of reassessment after neoadjuvant therapy and difficulties in interpretation, Diagn Interv Imaging, 2014;95:495-503.CrossRefPubMed Pierredon-Foulongne MA, Nougaret S, Bibeau F, et al., Utility of reassessment after neoadjuvant therapy and difficulties in interpretation, Diagn Interv Imaging, 2014;95:495-503.CrossRefPubMed
20.
Zurück zum Zitat Xie H, Sun T, Chen M, et al., Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer, Medicine, 2015;94(6):e517.CrossRefPubMedPubMedCentral Xie H, Sun T, Chen M, et al., Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer, Medicine, 2015;94(6):e517.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Song I, Kim SH, Lee SJ, et al., Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging, Br J Radiol, 2012;85:577-586.CrossRefPubMedPubMedCentral Song I, Kim SH, Lee SJ, et al., Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging, Br J Radiol, 2012;85:577-586.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Cai G, Xu Y, Zhu J, et al., Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation, World J Gastroenterol, 2013;19(33):5520-5527.CrossRefPubMedPubMedCentral Cai G, Xu Y, Zhu J, et al., Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation, World J Gastroenterol, 2013;19(33):5520-5527.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Moffat BA, Chenevert TL, Lawrence TS, et al., Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response, Proc Natl Acad Sci USA, 2005;102:5524-5529.CrossRefPubMedPubMedCentral Moffat BA, Chenevert TL, Lawrence TS, et al., Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response, Proc Natl Acad Sci USA, 2005;102:5524-5529.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kim SH, Lee JY, Lee JM, Han JK, Choi BI, Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer, Eur Radiol, 2011;21:987-995.CrossRefPubMed Kim SH, Lee JY, Lee JM, Han JK, Choi BI, Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer, Eur Radiol, 2011;21:987-995.CrossRefPubMed
25.
Zurück zum Zitat Lee EM, Hong YS, Kim KP, et al., Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer, Cancer Sci, 2013;104:111-115.CrossRefPubMed Lee EM, Hong YS, Kim KP, et al., Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer, Cancer Sci, 2013;104:111-115.CrossRefPubMed
26.
Zurück zum Zitat Curvo-Semedo L, Lambregts DMJ, Maas M, et al., Rectal Cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy - Conventional MR volumetry versus diffusion-weighted MR imaging, Radiology, 2011;260:734-743.CrossRefPubMed Curvo-Semedo L, Lambregts DMJ, Maas M, et al., Rectal Cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy - Conventional MR volumetry versus diffusion-weighted MR imaging, Radiology, 2011;260:734-743.CrossRefPubMed
27.
Zurück zum Zitat Dzik-Jurasz A, Domenig C, George M, et al., Diffusion MRI for prediction of response of rectal cancer to chemoradiation, Lancet, 2002;360:307-308.CrossRefPubMed Dzik-Jurasz A, Domenig C, George M, et al., Diffusion MRI for prediction of response of rectal cancer to chemoradiation, Lancet, 2002;360:307-308.CrossRefPubMed
28.
Zurück zum Zitat Koh DM, Collins DJ, Diffusion-weighted MRI in the body: applications and challenges in oncology, Am J Roentgenol, 2007;188:1622-1635.CrossRef Koh DM, Collins DJ, Diffusion-weighted MRI in the body: applications and challenges in oncology, Am J Roentgenol, 2007;188:1622-1635.CrossRef
29.
Zurück zum Zitat Harrison L, Blackwell K, Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?, Oncologist, 2004;9:31-40.CrossRefPubMed Harrison L, Blackwell K, Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?, Oncologist, 2004;9:31-40.CrossRefPubMed
30.
Zurück zum Zitat Jung SH, Heo SH, Kim JW, et al., Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging, J Magn Reson Imaging, 2012;35:110-116.CrossRefPubMed Jung SH, Heo SH, Kim JW, et al., Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging, J Magn Reson Imaging, 2012;35:110-116.CrossRefPubMed
31.
Zurück zum Zitat Petrelli F, Sgroi G, Sarti E, Barni S, Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies, Ann Surg, 2016;263:458-464.CrossRefPubMed Petrelli F, Sgroi G, Sarti E, Barni S, Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies, Ann Surg, 2016;263:458-464.CrossRefPubMed
32.
Zurück zum Zitat Probst CT, Becerra AZ, Aquina CT, et al., Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation, J Am Coll Surg, 2015;221(2):430-440.CrossRefPubMedPubMedCentral Probst CT, Becerra AZ, Aquina CT, et al., Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation, J Am Coll Surg, 2015;221(2):430-440.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Sloothaak DA, Geijsen DE, van Leersum NJ, et al., Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer, Br J Surg, 2013;100:933-939.CrossRefPubMed Sloothaak DA, Geijsen DE, van Leersum NJ, et al., Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer, Br J Surg, 2013;100:933-939.CrossRefPubMed
34.
Zurück zum Zitat Joye I, Debucquoy A, Deroose C, et al., Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer, Radiother Oncol, 2017;124(1):104-109.CrossRefPubMedPubMedCentral Joye I, Debucquoy A, Deroose C, et al., Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer, Radiother Oncol, 2017;124(1):104-109.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J, et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, 2009;45:228-247. Eisenhauer EA, Therasse P, Bogaerts J, et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, 2009;45:228-247.
36.
Zurück zum Zitat Xiao J, Tan Y, Li W, et al., Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: results from a prospective study, Oncol Lett, 2015;9(6):2680-2686.CrossRefPubMedPubMedCentral Xiao J, Tan Y, Li W, et al., Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: results from a prospective study, Oncol Lett, 2015;9(6):2680-2686.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Kim YC, Lim JS, Keum KC, et al., Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer, J Magn Reson Imaging, 2011; 34(3):570-576.CrossRefPubMed Kim YC, Lim JS, Keum KC, et al., Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer, J Magn Reson Imaging, 2011; 34(3):570-576.CrossRefPubMed
38.
Zurück zum Zitat Ha HI, Kim AY, Yu CS, Park SH, Ha HK, Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy, Eur Radiol, 2013;23(12):3345-3353.CrossRefPubMed Ha HI, Kim AY, Yu CS, Park SH, Ha HK, Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy, Eur Radiol, 2013;23(12):3345-3353.CrossRefPubMed
39.
Zurück zum Zitat Nougaret S, Vargas HA, Lakhman Y, et al., Intravoxel Incoherent Motion histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetric analyses, Radiology, 2016;280(2):446-454.CrossRefPubMed Nougaret S, Vargas HA, Lakhman Y, et al., Intravoxel Incoherent Motion histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetric analyses, Radiology, 2016;280(2):446-454.CrossRefPubMed
40.
Zurück zum Zitat Kim SH, Lee JM, Gupta SN, Han JK, Choi BI, Dynamic contrast enhancement MRI to evaluate the therapaeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer, J Magn Reson Imaging, 2014;40(3):730-737.CrossRefPubMed Kim SH, Lee JM, Gupta SN, Han JK, Choi BI, Dynamic contrast enhancement MRI to evaluate the therapaeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer, J Magn Reson Imaging, 2014;40(3):730-737.CrossRefPubMed
41.
Zurück zum Zitat Intven M, Monninkhof EM, Reerink O, Philippens ME, Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer, Acta Oncol, 2015;27:1-8. Intven M, Monninkhof EM, Reerink O, Philippens ME, Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer, Acta Oncol, 2015;27:1-8.
42.
Zurück zum Zitat Nie K, Shi L, Chen Q, et al., Rectal cancer: assessment of neoadjuvant chemo-radiation outcome based on radiomics of multi-parametric MRI, Clin Cancer Res, 2016;22(21):5256-5264.CrossRefPubMed Nie K, Shi L, Chen Q, et al., Rectal cancer: assessment of neoadjuvant chemo-radiation outcome based on radiomics of multi-parametric MRI, Clin Cancer Res, 2016;22(21):5256-5264.CrossRefPubMed
43.
Zurück zum Zitat Lambregts DMJ, Maas M, Riedl RG, et al., Value of ADC measurement for nodal staging after chemoradiation in locally advanced rectal cancer - a per lesion validation study, Eur Radiol, 2010;21:265-273.CrossRefPubMedPubMedCentral Lambregts DMJ, Maas M, Riedl RG, et al., Value of ADC measurement for nodal staging after chemoradiation in locally advanced rectal cancer - a per lesion validation study, Eur Radiol, 2010;21:265-273.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat van Heeswijk MM, Lambregts DMJ, Palm WM, et al., DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status?, Am J Roentgenol, 2017;208(3):w79-w84.CrossRef van Heeswijk MM, Lambregts DMJ, Palm WM, et al., DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status?, Am J Roentgenol, 2017;208(3):w79-w84.CrossRef
45.
Zurück zum Zitat Lahaye MJ, Engelen SM, Kessels AG, et al., USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria, Radiology, 2008;246:804-811.CrossRefPubMed Lahaye MJ, Engelen SM, Kessels AG, et al., USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria, Radiology, 2008;246:804-811.CrossRefPubMed
46.
Zurück zum Zitat Heijnen LA, Lambregts DMJ, Martens MH, et al., Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?, Eur Radiol, 2014;24:371-379.CrossRefPubMed Heijnen LA, Lambregts DMJ, Martens MH, et al., Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?, Eur Radiol, 2014;24:371-379.CrossRefPubMed
47.
Zurück zum Zitat Blazic IM, Lilic GB, Gajic MM, Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging, Radiology, 2017;282(2):418-428.CrossRefPubMed Blazic IM, Lilic GB, Gajic MM, Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging, Radiology, 2017;282(2):418-428.CrossRefPubMed
Metadaten
Titel
Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy
verfasst von
Maria Napoletano
Daniele Mazzucca
Enrico Prosperi
Maria Cristina Aisa
Marco Lupattelli
Cynthia Aristei
Michele Scialpi
Publikationsdatum
19.04.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02012-4

Weitere Artikel der Ausgabe 11/2019

Abdominal Radiology 11/2019 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.